STX3: A Protein Regulating Neuronal Communication and Cell Signaling

Target Name: STX3

NCBI ID: G6809

STX3

STX3: A Protein Regulating Neuronal Communication and Cell Signaling

Syntaxin 3A (STX3) is a protein that is expressed in the brain and is involved in the regulation of neural communication. It is a key protein in the syntaxin family, which is known for its role in the regulation of intracellular signaling pathways. STX3 has been shown to play a role in the regulation of various cellular processes, including neuronal communication, neurotransmitter release, and cell signaling. As a result, STX3 has potential as a drug target or biomarker for various neurological and psychiatric disorders.

The syntaxin family consists of four proteins: STX1, STX2, STX3, and STX4. These proteins are characterized by the presence of a unique C-terminus domain, which is involved in their interactions with other proteins. The C-terminus domain is also known as the \"syntaxin domain\" and is involved in the regulation of intracellular signaling pathways.

STX3 is a member of the syntaxin family and is expressed in the brain. It is involved in the regulation of various cellular processes, including neuronal communication, neurotransmitter release, and cell signaling. STX3 has been shown to play a role in the regulation of various signaling pathways, including the regulation of neuronal communication in the brain.

One of the key functions of STX3 is its role in the regulation of synaptic plasticity. Synaptic plasticity is the ability of the brain to change and adapt over time in response to various stimuli. STX3 is involved in the regulation of synaptic plasticity by controlling the release of neurotransmitters, such as dopamine and glutamate, which are involved in the regulation of neural communication.

STX3 has also been shown to play a role in the regulation of neurotransmitter release. Neurotransmitters are chemical messengers that are released from the axon terminal of neurons and help to regulate various cellular processes. STX3 is involved in the regulation of neurotransmitter release by controlling the trafficking of neurotransmitter release granules to the axon terminal of neurons.

In addition to its role in the regulation of neural communication, STX3 has also been shown to play a role in the regulation of cell signaling. Cell signaling is the process by which cells communicate with each other through the release of signaling molecules. STX3 is involved in the regulation of cell signaling by controlling the release of signaling molecules, such as neurotransmitters and growth factors.

STX3 has been shown to play a role in the regulation of various psychiatric and neurological disorders. For example, STX3 has been shown to be involved in the regulation of the symptoms of anxiety and depression. It has also been shown to play a role in the regulation of the symptoms of attention deficit hyperactivity disorder (ADHD), which is a disorder characterized by symptoms such as impulsivity and hyperactivity.

In conclusion, STX3 is a protein that is involved in the regulation of various cellular processes, including neuronal communication, neurotransmitter release, and cell signaling. Its role in these processes makes it a potential drug target or biomarker for various psychiatric and neurological disorders. Further research is needed to fully understand the role of STX3 in these processes and to develop effective treatments for these disorders.

Protein Name: Syntaxin 3

Functions: Potentially involved in docking of synaptic vesicles at presynaptic active zones. Apical receptor involved in membrane fusion of apical vesicles

The "STX3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STX3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets